Roche expects to make more than 100 million antibody tests monthly by end of 2020

Roche

Antibody tests are the key to open the economy. The Muslim Times has the best collection for the war against Covid 19

Source: CNBC

Swiss drugmaker Roche said on Sunday it expects to be able to produce “significantly more” than 100 million of its new antibody tests monthly by the end of 2020, doubling its current production.

Roche earlier on Sunday received an emergency use authorization from the U.S. Food and Drug Administration approving its test, which relies on taking intravenous blood samples to identify whether someone has previously been infected with the coronavirus and whether they have the antibodies to defend against it.

Roche said its Elecsys Anti-SARS-CoV-2 antibody test has a specificity greater than 99.8%, meaning very few false-positive tests, and that it can help assess people’s immune response to the virus. The company said it has already started shipping the new antibody test to top laboratories globally.

Reference and additional updates about coronavirus

The best of the Muslim Times’ collection for war against Covid 19:

In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.

Prime Minister Shinzo Abe says more than 30 countries have asked Japan for favipiravir (Avigan) to fight Covid 19

For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology

Kaiser Permanente launches first coronavirus vaccine trial

Corona Fear’s Cure: Chanting from the Bible and the Quran

Can You Chant from the Bible or the Quran to Bliss and Happiness?

Japanese flu drug ‘clearly effective’ in treating coronavirus, says China

Synthetic antibodies might offer a quick coronavirus treatment

The Four Possible Timelines for Life Returning to Normal

The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic

Coronavirus: TB Vaccination Trial Started in Melbourne, Australia

The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources

All of humanity are intimate neighbors: Coronavirus proves it once again

Praise be to God for the Miracle of Our Immune System

USA: 15-minute coronavirus test is here

Does the Ordinary Soap Kill Coronavirus?

Here’s a list of disinfectants you can use against coronavirus

For the number of cases and epidemiology in each country go to: WorldOMeters

Categories: Health, The Muslim Times

1 reply

  1. By Aakriti Bhalla and John Miller

    (Reuters) – Roche has won emergency approval from the U.S. Food and Drug Administration (FDA) for an antibody test to determine whether people have ever been infected with the coronavirus, the Swiss drugmaker on Sunday.

    Thomas Schinecker, Roche’s head of diagnostics, said the company aims to more than double production of tests from about 50 million a month to significantly more than 100 million a month by the end of the year.

    Governments, businesses and individuals are seeking such blood tests to learn who may have had the disease, who may have some immunity and to potentially craft strategies to help end national lockdowns.

    Basel-based Roche, which also makes molecular tests to identify active COVID-19 infections, said its antibody test has a specificity rate exceeding 99.8% and sensitivity of 100%, meaning tests would show very few false positives and no false negatives.

    A false-positive result could lead to the mistaken conclusion that someone has immunity. Roche said its test relies on intravenous blood draws, with higher accuracy than finger-prick tests.

    “If you take blood from a finger prick, you will never be able to achieve the same level of specificity that you will achieve … when you take blood from the vein,” Schinecker said.

    “You have to have very, very high specificity. Even 0.1% or 0.2% makes a difference.”

    RIVALS’ TESTS

    Similar antibody tests have also been developed by companies including U.S.-based Abbott Laboratories, Becton Dickinson and Italy’s DiaSorin.

    Abbott has said the specificity and sensitivity of its test are 99.5% and 100% respectively. Diasorin has said its Liason XL test has 97.4% sensitivity and 98.5% specificity.

    https://finance.yahoo.com/news/roche-aims-more-100-million-114259761.html

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.